SynthesisScientific reports2026
Meta-analysis of cellular phosphoproteome datasets exploring phospho-signaling associated with the RNA-binding protein RAVER1.
Synthesis in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Systematic Analysis of MRTFB Phosphoproteomic Datasets Reveals Co-Regulated Kinase Networks and Co-Occurring Phosphosites Associated with the Actin Cytoskeleton Pathway.Current issues in molecular biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
RAVER1 is a conserved PTBP1-associated regulator of alternative splicing with emerging roles in cytoskeletal organisation and proliferative signaling. Despite the central role of phosphorylation in intracellular signaling, phospho-dependent regulation of RAVER1 remains poorly defined. To address this gap, we performed a comprehensive meta-analysis of global human cellular phosphoproteome datasets to characterise RAVER1 phosphorylation and its associated signaling networks. Class I phosphosites were systematically compiled, and phosphosite-centric analyses were conducted to evaluate site predominance, co-occurrence patterns, phosphoproteome-wide co-regulation, and predicted upstream kinase associations. Thirteen Class I phosphosites were identified, of which S14, S17, and T463 emerged as predominant based on consistent detection across profiling and differential datasets. Significant phosphosite co-occurrence among S6, T8, and S14 within the N-terminal region suggests coordinated, context-dependent regulation and functional association of these sites. Phosphoproteome-wide co-regulation analysis linked RAVER1 phosphorylation states to proteins involved in RNA processing, cell-cycle regulation, and DNA repair. Kinase-oriented analyses identified CDK family members (CDK9, CDK12, and CDK13) as high-confidence predicted upstream kinases for RAVER1 S14. Notably, phosphosites in several epithelial–mesenchymal transition (EMT)-associated regulators, including KDM1A, VIM, and PTK2, showed positive co-regulation with RAVER1 phosphosites, consistent with multi-omics perturbation datasets reporting EMT-associated changes upon RAVER1 depletion. To our knowledge, this study provides the first phospho-signaling map of RAVER1 and establishes a phosphosite-centric analytical framework for functional investigation of RAVER1 phosphorylation, with potential implications for targeted therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.